Katy Moncivais holds a Ph.D. in Biomedical Engineering from The University of Texas at Austin.

She is a skilled medical communicator with extensive experience in the hospital and healthcare industries. Dr. Moncivais specializes in cellular therapies. She provides guidance on topics affecting mesothelioma patients and researchers, including cell/tissue culture, protein engineering and tRNA engineering. She speaks frequently at medical conferences and has been published on multiple topics including unnatural amino acid protein expression, mesenchymal stem cell-based tissue regeneration and stem cell transfection.

In her role at, Dr. Moncivais works alongside the writing, research and support staff to help deliver fact-based information to patients, their families and researchers. She also reviews medical content to ensure scientific accuracy, providing our clients with peace of mind.